ADULT RESIDENTIAL FACILITY (ARF) PRACTICE TEST
COMPREHENSIVE STUDY GUIDE 2026 FULL QUESTIONS
AND SOLUTIONS GRADED A+
● discuss the terms defined in the State and Federal Controlled Substances Acts (CSA);.
Answer: A"Controlled substance" means a substance, including a drug, an adulterant, and a
dilutant, listed in Schedules I through V or Penalty Group 1, 1-A, 2, 2-A, 3, or 4.AAThe term
includes the aggregate weight of any mixture, solution, or other substance containing a
controlled substance.
● 2. discuss who must register with the Drug Enforcement Administration (DEA);. Answer:
Every person who manufactures or distributes any controlled substance or list I chemical, or
who proposes to engage in the manufacture or distribution of any controlled substance or list I
chemical, shall obtain annually a registration issued by the Attorney General in accordance
with the rules and regulations promulgated by him. (2) Every person who dispenses, or who
proposes to dispense, any controlled substance, shall obtain from the Attorney General a
registration issued in accordance with the rules and regulations promulgated by him. The
Attorney General shall, by regulation, determine the period of such registrations. In no event,
however, shall such registrations be issued for less than one year nor for more than three
years.
● 3. describe types of registration and procedures for registering with DEA;. Answer:
Practitioners dispensing narcotic drugs for narcotic treatment; annual registration; separate
registration; qualifications; waiver (1) Except as provided in paragraph (2), practitioners who
dispense narcotic drugs to individuals for maintenance treatment or detoxification treatment
shall obtain annually a separate registration for that purpose. The Attorney General shall
register an applicant to dispense narcotic drugs to individuals for maintenance treatment or
detoxification treatment (or both) (A) if the applicant is a practitioner who is determined by the
Secretary to be qualified (under standards established by the Secretary) to engage in the
treatment with respect to which registration is sought; (B) if the Attorney General determines
that the applicant will comply with standards established by the Attorney General respecting
(i) security of stocks of narcotic drugs for such treatment, and (ii) the maintenance of records
(in accordance with section 827 of this title) on such drugs; and (C) if the Secretary
determines that the applicant will comply with standards established by the Secretary (after
consultation with the Attorney General) respecting the quantities of narcotic drugs which may
be provided for unsupervised use by individuals in such treatment
, ● 4. relate the procedures and limitations to distribute controlled substances from one
registrant to another without obtaining a second registration;. Answer: The transfer of original
prescription information for a controlled substance listed in Schedule III, IV, or V for the
purpose of refill dispensing is permissible between pharmacies on a one-time basis only.
However, pharmacies electronically sharing a real-time, online database may transfer up to
the maximum refills permitted by law and the prescriber's authorization. (b) Transfers are
subject to the following requirements: (1) The transfer must be communicated directly
between two licensed pharmacists. (2) The transferring pharmacist must do the following: (i)
Write the word "VOID" on the face of the invalidated prescription; for electronic prescriptions,
information that the prescription has been transferred must be added to the prescription
record. (ii) Record on the reverse of the invalidated prescription the name, address, and DEA
registration number of the pharmacy to which it was transferred and the name of the
pharmacist receiving the prescription information; for electronic prescriptions, such
information must be added to the prescription record. (iii) Record the date of the transfer and
the name of the pharmacist transferring the information. (3) For paper prescriptions and
prescriptions received orally and reduced to writing by the pharmacist pursuant to
§1306.21(a), the pharmacist receiving the transferred prescription information must write the
word "transfer" on the face of the transferred prescription and reduce to writing all information
required to be on a prescription pursuant to §1306.05 and include: (i) Date of issuance of
original prescription. (ii) Original number of refills authorized on original prescription. (iii) Date
of original dispensing. (iv) Number of valid refills remaining and date(s) and locations of
previous refill(s). (v) Pharmacy's name, address, DEA registration number, and prescription
number from which the prescription information was transferred. (vi) Name of pharmacist who
transferred the prescription
● 5. discuss the storage requirements for controlled substances in pharmacies;. Answer:
Schedules I and II. Raw material, bulk materials awaiting further processing, finished products
which are controlled substances listed in Schedule I or II (except GHB that is manufactured or
distributed in accordance with an exemption under section 505(i) of the Federal Food Drug
and Cosmetic Act which shall be subject to the requirements of paragraph (b) of this section),
and sealed mail-back packages and inner liners acquired in accordance with part 1317 of this
chapter, shall be stored in one of the following secured areas: (1) Where small quantities
permit, a safe or steel cabinet; (i) Which safe or steel cabinet shall have the following
specifications or the equivalent: 30 man-minutes against surreptitious entry, 10 man-minutes
against forced entry, 20 man-hours against lock manipulation, and 20 man-hours against
radiological techniques; (ii) Which safe or steel cabinet, if it weighs less than 750 pounds, is
bolted or cemented to the floor or wall in such a way that it cannot be readily removed; and (iii)
Which safe or steel cabinet, if necessary, depending upon the quantities and type of
controlled substances stored, is equipped with an alarm system which, upon attempted
COMPREHENSIVE STUDY GUIDE 2026 FULL QUESTIONS
AND SOLUTIONS GRADED A+
● discuss the terms defined in the State and Federal Controlled Substances Acts (CSA);.
Answer: A"Controlled substance" means a substance, including a drug, an adulterant, and a
dilutant, listed in Schedules I through V or Penalty Group 1, 1-A, 2, 2-A, 3, or 4.AAThe term
includes the aggregate weight of any mixture, solution, or other substance containing a
controlled substance.
● 2. discuss who must register with the Drug Enforcement Administration (DEA);. Answer:
Every person who manufactures or distributes any controlled substance or list I chemical, or
who proposes to engage in the manufacture or distribution of any controlled substance or list I
chemical, shall obtain annually a registration issued by the Attorney General in accordance
with the rules and regulations promulgated by him. (2) Every person who dispenses, or who
proposes to dispense, any controlled substance, shall obtain from the Attorney General a
registration issued in accordance with the rules and regulations promulgated by him. The
Attorney General shall, by regulation, determine the period of such registrations. In no event,
however, shall such registrations be issued for less than one year nor for more than three
years.
● 3. describe types of registration and procedures for registering with DEA;. Answer:
Practitioners dispensing narcotic drugs for narcotic treatment; annual registration; separate
registration; qualifications; waiver (1) Except as provided in paragraph (2), practitioners who
dispense narcotic drugs to individuals for maintenance treatment or detoxification treatment
shall obtain annually a separate registration for that purpose. The Attorney General shall
register an applicant to dispense narcotic drugs to individuals for maintenance treatment or
detoxification treatment (or both) (A) if the applicant is a practitioner who is determined by the
Secretary to be qualified (under standards established by the Secretary) to engage in the
treatment with respect to which registration is sought; (B) if the Attorney General determines
that the applicant will comply with standards established by the Attorney General respecting
(i) security of stocks of narcotic drugs for such treatment, and (ii) the maintenance of records
(in accordance with section 827 of this title) on such drugs; and (C) if the Secretary
determines that the applicant will comply with standards established by the Secretary (after
consultation with the Attorney General) respecting the quantities of narcotic drugs which may
be provided for unsupervised use by individuals in such treatment
, ● 4. relate the procedures and limitations to distribute controlled substances from one
registrant to another without obtaining a second registration;. Answer: The transfer of original
prescription information for a controlled substance listed in Schedule III, IV, or V for the
purpose of refill dispensing is permissible between pharmacies on a one-time basis only.
However, pharmacies electronically sharing a real-time, online database may transfer up to
the maximum refills permitted by law and the prescriber's authorization. (b) Transfers are
subject to the following requirements: (1) The transfer must be communicated directly
between two licensed pharmacists. (2) The transferring pharmacist must do the following: (i)
Write the word "VOID" on the face of the invalidated prescription; for electronic prescriptions,
information that the prescription has been transferred must be added to the prescription
record. (ii) Record on the reverse of the invalidated prescription the name, address, and DEA
registration number of the pharmacy to which it was transferred and the name of the
pharmacist receiving the prescription information; for electronic prescriptions, such
information must be added to the prescription record. (iii) Record the date of the transfer and
the name of the pharmacist transferring the information. (3) For paper prescriptions and
prescriptions received orally and reduced to writing by the pharmacist pursuant to
§1306.21(a), the pharmacist receiving the transferred prescription information must write the
word "transfer" on the face of the transferred prescription and reduce to writing all information
required to be on a prescription pursuant to §1306.05 and include: (i) Date of issuance of
original prescription. (ii) Original number of refills authorized on original prescription. (iii) Date
of original dispensing. (iv) Number of valid refills remaining and date(s) and locations of
previous refill(s). (v) Pharmacy's name, address, DEA registration number, and prescription
number from which the prescription information was transferred. (vi) Name of pharmacist who
transferred the prescription
● 5. discuss the storage requirements for controlled substances in pharmacies;. Answer:
Schedules I and II. Raw material, bulk materials awaiting further processing, finished products
which are controlled substances listed in Schedule I or II (except GHB that is manufactured or
distributed in accordance with an exemption under section 505(i) of the Federal Food Drug
and Cosmetic Act which shall be subject to the requirements of paragraph (b) of this section),
and sealed mail-back packages and inner liners acquired in accordance with part 1317 of this
chapter, shall be stored in one of the following secured areas: (1) Where small quantities
permit, a safe or steel cabinet; (i) Which safe or steel cabinet shall have the following
specifications or the equivalent: 30 man-minutes against surreptitious entry, 10 man-minutes
against forced entry, 20 man-hours against lock manipulation, and 20 man-hours against
radiological techniques; (ii) Which safe or steel cabinet, if it weighs less than 750 pounds, is
bolted or cemented to the floor or wall in such a way that it cannot be readily removed; and (iii)
Which safe or steel cabinet, if necessary, depending upon the quantities and type of
controlled substances stored, is equipped with an alarm system which, upon attempted
